Pure Global AI
NCT06337552Recruiting

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

A Randomized High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
H. Lee Moffitt Cancer Center and Research InstituteClinicalTrials.govother
Verified
Study focus
Disease/Condition
Rectal Cancer
Drug/Device/Intervention
FEED-FF
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
H. Lee Moffitt Cancer Center and Research Institute
Location
Tampa, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 19, 2024
End date
Mar 01, 2027
Enrollment
30 participants
Primary outcome

Effects of the FEED-FF diet on clinical response to chemoradiation,Effects of FEED-FF diet on the gut microbiome,Effects of FEED-FF diet on local immune-related biomarkers,Effects of FEED-FF diet on quality of life,Efficacy of the FEED-FF intervention,Feasibility of the FEED-FF intervention

Summary

The purpose of the study is to evaluate the feasibility and acceptability of a dietary
 intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal
 cancer patients, and to explore whether this diet can improve outcomes in rectal cancer
 patients receiving chemoradiotherapy (CRT).

ICD-10 classifications
Malignant neoplasm of rectumCarcinoma in situ: RectumBenign neoplasm: RectumSecondary malignant neoplasm of large intestine and rectumCarcinoma in situ: Rectosigmoid junction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06337552
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06337552 through Pure Global AI's free database. This phase not specified trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.